Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakkaraiappan Ramalingam

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|July 22, 2004
Paclitaxel for non-small cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|February 18, 2004
Cyclooxygenase-2 inhibitors in lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Hematology/Oncology Clinics of North America|March 10, 2004
Basic treatment considerations: chemotherapySakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|April 23, 2005
Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancerChandra P Belani, Sakkaraiappan Ramalingam
Oncology (Williston Park, N.Y.)|September 2, 2004
Carboplatin/gemcitabine combination in advanced NSCLCSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|February 8, 2005
Implications of the Iressa Survival Evaluation in Lung Cancer trial and the future of gefitinibChandra P Belani, Sakkaraiappan Ramalingam
Clinical Lung Cancer|December 5, 2003
Impact of INTACT: do we change the target or the aim?Sakkaraiappan Ramalingam, Chandra P Belani
Seminars in Oncology|February 26, 2004
State-of-the-art chemotherapy for advanced non-small cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|April 17, 2004
Smoking cessation and treatment outcomeChandra P Belani, Sakkaraiappan Ramalingam
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|July 22, 2004
Paclitaxel for non-small cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|February 18, 2004
Cyclooxygenase-2 inhibitors in lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Hematology/Oncology Clinics of North America|March 10, 2004
Basic treatment considerations: chemotherapySakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|April 23, 2005
Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancerChandra P Belani, Sakkaraiappan Ramalingam
Oncology (Williston Park, N.Y.)|September 2, 2004
Carboplatin/gemcitabine combination in advanced NSCLCSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|February 8, 2005
Implications of the Iressa Survival Evaluation in Lung Cancer trial and the future of gefitinibChandra P Belani, Sakkaraiappan Ramalingam
Clinical Lung Cancer|December 5, 2003
Impact of INTACT: do we change the target or the aim?Sakkaraiappan Ramalingam, Chandra P Belani
Seminars in Oncology|February 26, 2004
State-of-the-art chemotherapy for advanced non-small cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|April 17, 2004
Smoking cessation and treatment outcomeChandra P Belani, Sakkaraiappan Ramalingam
Pageof 2